A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
The Herbert Irving Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
Research from Columbia shows that nerves play a critical role in stomach cancer growth and blocking nerve signals using surgery or Botox® could provide an effective therapy for the disease.
New technology allows scientists to dive into the inner world of cells in everything from cancers to mummies. Learn more at lab’s open house on July 10.